Works about PROSTATE-specific membrane antigen


Results: 718
    1
    2
    3
    4
    5

    Synthesis of DOTA-Based 43 Sc Radiopharmaceuticals Using Cyclotron-Produced 43 Sc as Exemplified by [ 43 Sc]Sc-PSMA-617 for PSMA PET Imaging.

    Published in:
    Methods & Protocols, 2025, v. 8, n. 3, p. 58, doi. 10.3390/mps8030058
    By:
    • Meier, Jason P.;
    • Bhuiyan, Mohammed;
    • Freifelder, Richard;
    • Zhang, Hannah J.;
    • Gonzalez, Lucas;
    • Pusateri, Antonino;
    • Tsai, Hsiu-Ming;
    • Leoni, Lara;
    • Ghosh, Kaustab;
    • Markiewicz, Erica;
    • Henning, Christopher;
    • Zhang, Yuhan;
    • Weichselbaum, Ralph;
    • Nolen, Jerry;
    • Rotsch, David A.;
    • Kao, Chien-Min;
    • Szmulewitz, Russell Z.;
    • Chen, Chin-Tu;
    • Chitneni, Satish K.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Head-to-head comparison of prostate-specific membrane antigen PET and multiparametric MRI in the diagnosis of pretreatment patients with prostate cancer: a meta-analysis.

    Published in:
    European Radiology, 2024, v. 34, n. 6, p. 4017, doi. 10.1007/s00330-023-10436-2
    By:
    • Ma, Jianglei;
    • Yang, Qinqin;
    • Ye, Xiaofei;
    • Xu, Weidong;
    • Chang, Yifan;
    • Chen, Rui;
    • Wang, Ye;
    • Luo, Mengting;
    • Lou, Yihaoyun;
    • Yang, Xuming;
    • Li, Duocai;
    • Xu, Yusi;
    • He, Wei;
    • Cai, Minglei;
    • Cao, Wanli;
    • Ju, Guanqun;
    • Yin, Lei;
    • Wang, Junkai;
    • Ren, Jizhong;
    • Ma, Zifang
    Publication type:
    Article
    12
    14
    15
    16
    17
    18
    19
    20

    The Sensitivity and Specificity of Multiparametric Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Predicting Seminal Vesicle Invasion in Clinically Significant Prostate Cancer: A Multicenter Retrospective Study

    Published in:
    Journal of Clinical Medicine, 2024, v. 13, n. 15, p. 4424, doi. 10.3390/jcm13154424
    By:
    • Sitharthan, Darshan;
    • Kang, Song;
    • Treacy, Patrick-Julien;
    • Bird, Jacob;
    • Alexander, Kate;
    • Karunaratne, Sascha;
    • Leslie, Scott;
    • Chan, Lewis;
    • Steffens, Daniel;
    • Thanigasalam, Ruban
    Publication type:
    Article
    21
    22
    23
    24
    25
    26

    A Retrospective Analysis of the Safety and Activity of Lutetium‐177‐Prostate‐Specific Membrane Antigen Radionuclide Treatment in Older Patients with Metastatic Castration‐Resistant Prostate Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 9, p. 787, doi. 10.1634/theoncologist.2020-0100
    By:
    • Leibowitz, Raya;
    • Davidson, Tima;
    • Gadot, Moran;
    • Aharon, Margalit;
    • Malki, Avraham;
    • Levartovsky, Meital;
    • Oedegaard, Cecilie;
    • Saad, Akram;
    • Sandler, Israel;
    • Ben‐Haim, Simona;
    • Domachevsky, Liran;
    • Berger, Raanan
    Publication type:
    Article
    27

    Pilot Study of Hyperfractionated Dosing of Lutetium‐177–Labeled Antiprostate‐Specific Membrane Antigen Monoclonal Antibody J591 (<sup>177</sup>Lu‐J591) for Metastatic Castration‐Resistant Prostate Cancer.

    Published in:
    Oncologist, 2020, v. 25, n. 6, p. 477, doi. 10.1634/theoncologist.2020-0028
    By:
    • Niaz, Muhammad Junaid;
    • Batra, Jaspreet S.;
    • Walsh, Ryan D.;
    • Ramirez‐Fort, Marigdalia K.;
    • Vallabhajosula, Shankar;
    • Jhanwar, Yuliya S.;
    • Molina, Ana M.;
    • Nanus, David M.;
    • Osborne, Joseph R.;
    • Bander, Neil H.;
    • Tagawa, Scott T.
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50